PDS Biotechnology Corp — Director's Dealing 2019

Mar 26, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2019-03-15

Reporting Person: BEDU-ADDO FRANK (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	620507	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$4.69	2020-01-01	Common Stock (17724)		Direct
Employee Stock Option (Right to Buy)	$6.57	2021-07-27	Common Stock (53174)		Direct
Employee Stock Option (Right to Buy)	$6.57	2022-12-03	Common Stock (219535)		Direct
Employee Stock Option (Right to Buy)	$9.04	2029-03-14	Common Stock (53173)		Direct
Employee Stock Option (Right to Buy)	$9.04	2029-03-14	Common Stock (179786)		Direct

Footnotes

F1: Stock Option fully vested in accordance with its terms

F2: Stock Option fully vested on date of grant.